BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
According to Microbiome Times, Ilya Pharma has received a BIO-X® grant to study gene therapy for patients with inflammatory bowel disease. Their chemokine-based gene therapy drug candidates seek to…